Innate Pharma (IPHA) Treasury Shares (2020 - 2025)

Innate Pharma (IPHA) has reported Treasury Shares for 6 consecutive years, with $21137.5 the latest figure, recorded in Q4 2025.

• Quarterly Treasury Shares changed 0.0% year-over-year to $21137.5 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21137.5 (changed 0.0% YoY) and the FY2025 annual result came in at $21137.5, changed 0.0% from the prior year.
• Treasury Shares held at $21137.5 in Q4 2025 per IPHA's latest filing, from $21137.5 in the prior quarter.
• Over the last five years, Treasury Shares for IPHA reached as high as $21137.5 in Q2 2021 and fell as low as $21137.5 in Q2 2021.
• A 5-year average of $21137.5 and a median of $21137.5 in 2021 frame the typical range for Treasury Shares.
• The largest YoY upside for Treasury Shares was 0.0% in 2021 against a maximum downside of 0.0% in 2021.
• Year by year, Treasury Shares stood at $21137.5 in 2021, then changed by 0.0% to $21137.5 in 2022, then changed by 0.0% to $21137.5 in 2023, then changed by 0.0% to $21137.5 in 2024, then changed by 0.0% to $21137.5 in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $21137.5, $21137.5, and $21137.5 for Q4 2025, Q2 2025, and Q4 2024 respectively.